# FDA Inspection 989544 - OneLegacy - September 23, 2016

Source: https://www.keypedia.com/records/fda_inspections/onelegacy/b5103a59-3f45-4315-bc3d-981dde9028f4
Source feed: FDA_Inspections

> FDA Inspection 989544 for OneLegacy on September 23, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 989544
- Company Name: OneLegacy
- Inspection Date: 2016-09-23
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1243810 - 2024-07-01](https://www.keypedia.com/records/fda_inspections/onelegacy/d36f2e2d-a1bf-410e-ac70-35ce9ddd0d9e)
- [FDA Inspection 1102405 - 2019-07-26](https://www.keypedia.com/records/fda_inspections/onelegacy/26cf1874-ebaf-4338-a988-c47fbaa3336c)
- [FDA Inspection 857702 - 2013-12-05](https://www.keypedia.com/records/fda_inspections/onelegacy/3fc698da-8861-4e9e-84a1-d6e6eabd9044)
- [FDA Inspection 752525 - 2011-11-09](https://www.keypedia.com/records/fda_inspections/onelegacy/141a7b52-2913-450d-b8ce-603af8edfe0a)

Company: https://www.keypedia.com/companies/onelegacy/7bc514ef-2f5c-4065-8154-07320109ed6d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d